Jasmin Oztekin was Promoted as Senior International Corporate Counsel at CTI-Clinical-Trial-and-Consulting-Services

Date of management change: August 08, 2019 

What Happened?

Covington, -based CTI-Clinical-Trial-and-Consulting-Services Promoted Jasmin Oztekin as Senior International Corporate Counsel

 

About the Company

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI`s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific.

 

About the Person

Jasmin Oztekin is Senior International Corporate Counsel at CTI Clinical Trial and Consulting Services. Previously, Jasmin held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Lemke Christopher, Kolloway Mike, Moore Carol, Bushore Michelle, Morales Singh Beth, McCullough Georgia, Abreu Heidy, Deedwania Anne, Bridges JD, Mills Joshua, Lee Christina

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.